WallStreetZenWallStreetZen

NASDAQ: NVCT
Nuvectis Pharma Inc Stock Ownership - Who owns Nuvectis Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nuvectis Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ron BentsurChairman CEO2026-06-3012,500$20.00
$250.00kBuy
Marlio Charles Mosseri10% Owner2026-06-3050,000$18.32
$916.00kBuy
Ron BentsurChairman CEO2025-11-055,000$5.72
$28.60kBuy
Matthew L. KaplanDirector2025-11-0511,000$5.84
$64.24kBuy
Juan SanchezDirector2025-11-0513,000$5.79
$75.27kBuy

1 of 1

NVCT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVCT insiders and whales buy or sell their stock.

NVCT Shareholders

What type of owners hold Nuvectis Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ron Bentsur11.32%3,688,424$68.16MInsider
Marlio Charles Mosseri10.12%3,295,897$60.91MInsider
Enrique Poradosu5.54%1,806,319$33.38MInsider
Shay Shemesh5.50%1,793,068$33.14MInsider
Michael J. Carson0.71%230,118$4.25MInsider
Kenneth Hoberman0.52%168,140$3.11MInsider
Matthew L. Kaplan0.49%159,760$2.95MInsider
James F. Oliviero Iii0.38%122,828$2.27MInsider
Juan Sanchez0.35%113,795$2.10MInsider
URI Benor0.08%25,584$472.79kInsider

1 of 3

NVCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVCT0.03%35.00%Net Buying
AURA0.09%4.39%Net Selling
FDMT0.11%22.42%Net SellingNet Selling
CADL0.07%22.78%Net BuyingNet Selling
OLMA0.12%29.01%Net Selling
View Top Biotech Stocks

Nuvectis Pharma Stock Ownership FAQ

Who owns Nuvectis Pharma?

Nuvectis Pharma (NASDAQ: NVCT) is owned by 0.03% institutional shareholders, 35.00% Nuvectis Pharma insiders, and 64.97% retail investors. Ron Bentsur is the largest individual Nuvectis Pharma shareholder, owning 3.69M shares representing 11.32% of the company. Ron Bentsur's Nuvectis Pharma shares are currently valued at $70.74M.

If you're new to stock investing, here's how to buy Nuvectis Pharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.